These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17219251)

  • 1. Osteopontin in metastatic lesions as a prognostic marker in ovarian cancers.
    Bao LH; Sakaguchi H; Fujimoto J; Tamaya T
    J Biomed Sci; 2007 May; 14(3):373-81. PubMed ID: 17219251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of osteopontin in metastatic lesions of uterine cervical cancers.
    Sakaguchi H; Fujimoto J; Hong BL; Tamaya T
    Cancer Lett; 2007 Mar; 247(1):98-102. PubMed ID: 16675104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of osteopontin expression in human gastric carcinoma.
    Higashiyama M; Ito T; Tanaka E; Shimada Y
    Ann Surg Oncol; 2007 Dec; 14(12):3419-27. PubMed ID: 17896150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer.
    Rudland PS; Platt-Higgins A; El-Tanani M; De Silva Rudland S; Barraclough R; Winstanley JH; Howitt R; West CR
    Cancer Res; 2002 Jun; 62(12):3417-27. PubMed ID: 12067984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of osteopontin in hepatitis B virus-related hepatocellular carcinoma.
    Xie H; Song J; Du R; Liu K; Wang J; Tang H; Bai F; Liang J; Lin T; Liu J; Fan D
    Dig Liver Dis; 2007 Feb; 39(2):167-72. PubMed ID: 17161983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of expression of ETS-1 related to angiogenesis in metastatic lesions of ovarian cancers.
    Fujimoto J; Aoki I; Toyoki H; Khatun S; Sato E; Sakaguchi H; Tamaya T
    Oncology; 2004; 66(5):420-8. PubMed ID: 15331930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of expression of vascular endothelial growth factor in metastatic lesions of ovarian cancers.
    Fujimoto J; Sakaguchi H; Aoki I; Khatun S; Tamaya T
    Br J Cancer; 2001 Aug; 85(3):313-6. PubMed ID: 11487257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein expression of osteopontin in tumor tissues is an independent prognostic indicator in gastric cancer.
    Dai N; Bao Q; Lu A; Li J
    Oncology; 2007; 72(1-2):89-96. PubMed ID: 18004082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin expression correlates with prognostic variables and survival in clear cell renal cell carcinoma.
    Matusan K; Dordevic G; Stipic D; Mozetic V; Lucin K
    J Surg Oncol; 2006 Sep; 94(4):325-31. PubMed ID: 16917865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma osteopontin is an independent prognostic marker for head and neck cancers.
    Petrik D; Lavori PW; Cao H; Zhu Y; Wong P; Christofferson E; Kaplan MJ; Pinto HA; Sutphin P; Koong AC; Giaccia AJ; Le QT
    J Clin Oncol; 2006 Nov; 24(33):5291-7. PubMed ID: 17114663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival.
    Singhal H; Bautista DS; Tonkin KS; O'Malley FP; Tuck AB; Chambers AF; Harris JF
    Clin Cancer Res; 1997 Apr; 3(4):605-11. PubMed ID: 9815727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative plasma osteopontin level as a biomarker complementary to carbohydrate antigen 125 in predicting ovarian cancer.
    Nakae M; Iwamoto I; Fujino T; Maehata Y; Togami S; Yoshinaga M; Douchi T
    J Obstet Gynaecol Res; 2006 Jun; 32(3):309-14. PubMed ID: 16764622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of osteopontin expression in T1 and T2 tongue cancers.
    Chien CY; Su CY; Chuang HC; Fang FM; Huang HY; Chen CM; Chen CH; Huang CC
    Head Neck; 2008 Jun; 30(6):776-81. PubMed ID: 18228527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of phosphorylated protein kinase B and PTEN protein in ovarian epithelial cancer].
    Qiao YH; Cheng J; Guo RX
    Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):325-9. PubMed ID: 17673045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protein and mRNA expression of osteopontin in lung cancer and clinical significance thereof].
    Gui SY; Li HH; Zuo L; Zhou Q; Wu Q; Wang Y
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(45):3219-23. PubMed ID: 18399118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer.
    Schorge JO; Drake RD; Lee H; Skates SJ; Rajanbabu R; Miller DS; Kim JH; Cramer DW; Berkowitz RS; Mok SC
    Clin Cancer Res; 2004 May; 10(10):3474-8. PubMed ID: 15161704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and clinical significance of uPA and PAI-1 in epithelial ovarian cancer].
    Cai Z; Li YF; Liu FY; Feng YL; Hou JH; Zhao MQ
    Ai Zheng; 2007 Mar; 26(3):312-7. PubMed ID: 17355798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer.
    Anttila MA; Tammi RH; Tammi MI; Syrjänen KJ; Saarikoski SV; Kosma VM
    Cancer Res; 2000 Jan; 60(1):150-5. PubMed ID: 10646867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression.
    Castellano G; Malaponte G; Mazzarino MC; Figini M; Marchese F; Gangemi P; Travali S; Stivala F; Canevari S; Libra M
    Clin Cancer Res; 2008 Nov; 14(22):7470-80. PubMed ID: 19010864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer.
    Chang YS; Kim HJ; Chang J; Ahn CM; Kim SK; Kim SK
    Lung Cancer; 2007 Sep; 57(3):373-80. PubMed ID: 17513004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.